TAMMI PAVEY: Open Payments
NPI 1447457965 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,226 in 81 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $1,240 · 2025 $2,226
Food & beverage: $2,226
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $380 |
| Corcept Therapeutics | 11 | $349 |
| Amgen Inc. | 7 | $235 |
| Lilly USA, LLC | 7 | $163 |
| SANOFI-AVENTIS U.S. LLC | 5 | $162 |
| Mannkind Corporation | 5 | $141 |
| BETA BIONICS, INC. | 1 | $121 |
| Madrigal Pharmaceuticals | 3 | $112 |
| Ascendis Pharma Endocrinology Inc | 3 | $68 |
| Dexcom, Inc. | 3 | $61 |
Products named: Korlym, Ozempic, MOUNJARO, TZIELD, AFREZZA, iLet Bionic Pancreas, REZDIFFRA, TEPEZZA.
Industry payments across GA — which companies pay providers there.
